Irina Haivas
Irina is a healthcare specialist with a background in medicine and management consulting. She previously spent seven years with Bain & Company, where she was a leader in the European healthcare practice, and brings a wealth of experience across Europe, the US and emerging markets to the firm. Irina has advised multiple private equity funds on healthcare due diligence and post-acquisition projects, and has worked directly with pharmaceutical, biotechnology, and healthcare services companies on strategic initiatives including growth, business models, R&D and innovation, M&A, organisational development and operational improvement.
Irina is a medical doctor with a first-in-class degree and experience across multiple healthcare systems. She studied medicine at Iasi Medical University in Romania and Freiburg University in Germany as a Rotary Scholar, and was a visiting surgical fellow at Harvard Medical School. She also holds a MSc in International Health Policy from London School of Economics where she graduated with distinction. A native Romanian speaker, Irina is fluent in English and German and is conversational in French and Italian.
Samer Al-Murrani
Marie-Paul Lachaud
Marie-Paul Lachaud, DVM is Head of Program Management Europe at Aratana Therapeutics. Her responsibilities include coordinating the process leading to regulatory approval by the European Medicines Agency for Aratana’s products targeted at unmet medical needs in cats and dogs.
Prior to joining Aratana, Dr. Lachaud served the veterinary pharmaceutical industry as an experienced consultant, with a specific focus on international drug clinical development.
From 2000 to 2008, Dr. Lachaud was the European animal health director at ICON Clinical Research in Paris, France. In 1990, she co-founded PROTOCOLE, the first European veterinary consultancy and contract research organization focused on drug clinical development and regulatory affairs, which was acquired by ICON in 2000.
Dr. Lachaud has been involved in transitioning human drugs to meet unmet needs in veterinary medicine for years. Her work has resulted in significant animal health product approvals in Europe and the United-States for companion animals in a number of innovative therapeutic areas, including reproduction, chronic heart failure, chronic kidney disease, pain management, oncology and neurobehavioral disorders.
She received her veterinary degree from Alfort National Veterinary School in Paris and her doctorate in veterinary medicine from the University of Paris, France.
Randolph Seidler
Mark Engel
